Introduction: Nuclear factor kappa B (NF-kB) is an important transcriptional regulator of angiogenesis involving B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax) signaling pathways. Thus, inhibition of NF-kB may suppress the development of periapical lesions via blockage of angiogenesis. Accordingly, we examined the effects of NF-kB decoy oligodeoxynucleotide (ODN) treatment on experimentally induced periapical lesions. Methods: Periapical lesions were induced in the mandibular first molars of 5-week-old male Wistar rats by the application of lipopolysaccharide to the pulp. NF-kB decoy ODN or NF-kB decoy scramble (control) was injected intraperitoneally every 7 days, starting 1 day before pulp exposure. After 28 days, the samples were retrieved, and digital radiographs were taken for radiomorphometry. Samples were processed for (1) immunohistochemistry of CD31, Bcl-2, and Bax; (2) laser capture microdissection to analyze Bcl-2, Bax, chemokine (C-X-C motif) ligand 1 (CXCL1), CXC receptor 2 (CXCR2), and vascular endothelial cell growth factor receptor 2 (VEGFR2) messenger RNA (mRNA) expression in CD31+ endothelial cells; (3) enzymelinked immunosorbent assay to determine NF-kB/p65 activity; and (4) Western blotting for vascular endothelial growth factor expression. Results: NF-kB decoy ODN treatment significantly reduced lesion size, NF-kB/p65 activity, and the density of CD31+ endothelial cells in the lesion. NF-kB decoy ODNs also down-regulated CXCL1, CXCR2, and VEGFR2 mRNAs and up-regulated Bax mRNA in endothelial cells but did not affect Bcl2 mRNA in endothelial cells. Vascular endothelial growth factor protein expression in the lesions was significantly decreased. Conclusions: The inhibition of NF-kB activity by decoy ODN treatment suppressed the development of experimentally induced periapical lesions with a concomitant reduction in angiogenic responses in endothelial cells. (J Endod 2019;45:168-173) 
A pical periodontitis is a common oral inflammatory disease caused by bacterial infection in the root canal system and is characterized by the formation of granulation tissues with concomitant bone resorption in the periradicular region (1, 2) . This disease involves complex cellular and molecular mechanisms in which various bioactive molecules, such as cytokines, lytic enzymes, and growth factors, contribute to tissue destruction (1, 2) .
Angiogenesis is the growth of new blood vessels from preexisting vasculature and is essential for several pathological and physiological processes, including granulation tissue development and wound healing (3) . Abnormal or excessive angiogenesis is a characteristic of several disorders, such as cancer (4) and chronic inflammation (5) . Angiogenesis is mediated by several cytokines and chemokines including interleukin (IL) 1, IL-8, and tumor necrosis factor alpha (6) . Moreover, angiogenic factors, such as fibroblast growth factor (7) and vascular endothelial cell growth factor (VEGF) (7) , have been detected in periapical lesions. In experimentally induced rat periapical lesions, an increase in microvascular density and up-regulation of messenger RNA (mRNA) encoding angiogenic factors, such as vascular endothelial growth factor receptor 2 (VEGFR2), B-cell lymphoma 2 (Bcl 2, a prosurvival and proangiogenic signaling molecule), chemokine (C-X-C motif) ligand 1 (CXCL1, a proangiogenic chemokine), and CXC receptor 2 (CXCR2), in endothelial cells occur coincidently with the expanding phase of the lesion (8) . These findings suggest these angiogenic factors have critical roles in the pathogenesis of apical periodontitis.
Nuclear factor kappa B (NF-kB) is activated by various neurotoxic and apoptotic stimuli (9) . NF-kB induces the expression of several proapoptotic molecules, such as Bcl-2-associated X protein (Bax) and Bcl-2 (10). Apoptosis is induced by up-regulation of Bax, activation of caspases, and down-regulation of Bcl-2 (11). Furthermore, NF-kB is a critical factor in angiogenesis, particularly in oncology (12) . For example, tumor cell-derived vascular endothelial growth factor (VEGF) induces Bcl-2 expression in endothelial cells, which, in turn, activates NF-kB and up-regulates the expression of proangiogenic chemokines CXCL1 and chemokine (C-X-C motif) ligand 8 (CXCL8) (13) . Thus, the inhibition of NF-kB in the angiogenic pathway may suppress angiogenesis and reduce periapical lesions (14) .
Recently developed gene therapies include decoy oligonucleotides and oligodeoxynucleotides (ODNs) (15) . Decoy oligonucleotides are short synthetic fragments of DNA or RNA, which mimic complementary nucleic acid sequences to prevent transcription factor binding to target gene promoter regions. Because of target recognition specificity, off-target effects are limited (16) . ODNs are decoys for specific transcription factors that attenuate authentic cis-trans interactions and facilitate removal of trans-factors from endogenous cis-elements, thereby modulating gene expression.
We hypothesized that the inhibition of NF-kB suppresses periapical lesion development via blockage of angiogenesis. In this study, we examined the effects of NF-kB decoy ODN treatment on experimentally induced periapical lesions.
Materials and Methods

Animal Preparation
All rats were used in compliance with the guidelines of the Niigata University Intramural Animal Use and Care Committee. Five-week-old male Wistar rats (N = 24) were anesthetized by an intraperitoneal injection of 8% chloral hydrate (350 mg/kg). Pulp exposure was performed at the occlusal surface of both sides of the mandibular first molars, and 1 mL lipopolysaccharide (from Escherichia coli 0111:B4; Sigma-Aldrich, St Louis, MO; 10 mg/mL) was applied to the pulp with sterile paper points. Pulp cavities were sealed with a temporary filling material (Caviton; GC, Tokyo, Japan). In the experimental group of animals (n = 12), 2 mL saline containing ribbon-type NF-kB decoy ODN (NF-kB decoy; Gene Design, Inc, Osaka, Japan) was injected intraperitoneally 1 day before pulp exposure and on days 6, 13, 20, and 27 after pulp exposure (50 nmol/week). In control animals (n = 12), ribbon-type NF-kB decoy scramble (50 nmol/week; Gene Design, Inc) was administered in a similar manner.
Sample Preparation
On day 28 after lesion induction, animals were sacrificed by transcardiac perfusion of periodate lysine paraformaldehyde fixative, except for animals analyzed by Western blotting. Both sides of the mandibular first molars were retrieved with the surrounding bones and soaked in the same fixative for 24 hours.
Eight rats were used for immunohistochemistry and enzymelinked immunosorbent assay (ELISA). Immediately after retrieval of the right mandibles (n = 4 in each group), digital radiographs were taken as described later. The specimens were demineralized with 10% EDTA, embedded as frozen blocks, and sliced in 8-mm sections (CM1900; Leica, Wetzlar, Germany) for immunohistochemistry.
For laser capture microdissection (LCM, n = 8 rats), the right first molars (n = 4 in each group) were retrieved and demineralized with a mixture of 10% EDTA and storage medium (RNAlater; Thermo Fisher Scientific, Waltham, MA). Frozen samples were cut into 30-mm sections and mounted on glass slides with a PEN foil membrane for LCM (Leica Microsystems). Four serial sections with the root apex were selected and used for LCM.
For Western blot analysis, rats (n = 8) were sacrificed by intraperitoneal injection of an overdose of 8% chloral hydrate. The right first molars (n = 4 in each group) were retrieved and demineralized with a mixture of 10% EDTA and storage medium (RNAlater; Thermo Fisher Scientific). Frozen samples were cut into 30-mm sections and mounted on glass slides for LCM (Leica Microsystems). Four serial sections with the root apex were selected and used for Western blot analysis.
Digital Morphometric Analysis
Digital radiographs of the right mandibles in both groups (n = 8) were taken with image capture in a digital radiograph unit (Venus; Yoshida Seikou, Ltd, Ibaraki, Japan, and Trophy Windows; Trophy Radiologie Japan, Tokyo, Japan), and the size of the radiolucent area around the distal root was measured using ImageJ software (Version 1.37v; National Institutes of Health, Bethesda, MD).
ELISA for NF-kB p65 Activity NF-kB activity was assessed by the level of p65 in the nuclear fraction using the NF-kB/p65 ActivELISA kit (Imgenex, San Diego, CA). Nuclear extracts were prepared and subjected to a sandwich ELISA according to the manufacturer's protocol. The optical density of samples was determined using an ELISA microplate reader (Infinite F50; Tecan, Mannedorf, Switzerland) at 450 nm.
Immunohistochemistry
Immunoperoxidase staining was performed with monoclonal anti-CD31 antibodies (a general endothelial cell marker [Serotec, Oxford, UK]; diluted 1:100), polyclonal anti-Bcl-2 antibodies (Millipore, Burlington, MA; diluted 1:2000), or polyclonal anti-Bax antibodies (Novus Biologicals; diluted 1:300) as previously described (8) . Secondary antibodies were biotinylated horse antimouse immunoglobulin G (Vector Laboratories, Burlingame, CA) for anti-CD31 and biotinylated goat antirabbit immunoglobulin G (Vector Laboratories) for anti-Bcl-2 and anti-Bax. Immunoreactivity was visualized with a DAB Substrate Kit (Vector Laboratories). Negative control staining was performed in parallel by incubating sections with phosphate-buffered saline instead of primary antibody.
For quantitative analysis, 5 randomly selected fields (200 mm Â 100 mm) from a representative section per sample were displayed on a monitor connected to a light microscope (Nikon, Tokyo, Japan) at 40Â magnification (objective lens) as previously described (17) . The immunostained area was plotted, and pixel counts were determined using ImageJ software (Version 1.37v). The percentage of the immunostained area in the total area and Bax/Bcl-2 ratios were calculated.
LCM and Real-time Polymerase Chain Reaction
Immunoperoxidase staining for CD31 was performed as described previously. Cell collection was performed with an LCM microscope (Leica AS LMD, Leica) with a pulsed 337-nm ultraviolet laser. Approximately 200 CD31+ endothelial cells in periapical lesions were retrieved as previously described (18) . Total RNA was extracted and purified (n = 4) as previously described (19 [GAPDH]) were obtained from Applied Biosystems. Total RNA (0.01 mg/30 mL reaction mixture) was prepared using TaqMan Universal PCR Master Mix (Applied Biosystems). The reactions were incubated in 48-well clear optical reaction plates using the StepOne Sequence Detection System (Applied Biosystems), and the data were normalized by the data for GAPDH as a control.
Western Blotting
The periapical lesion area was retrieved from the glass slides using a microsurgery knife under a stereomicroscope. The total protein was extracted from the retrieved periapical lesion samples (n = 4 teeth in each experimental group), subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis, transferred to membranes, probed with primary antibodies against VEGF (R&D Systems, Minneapolis, MN) or GAPDH (GeneTex, Irvine, CA), and then probed with peroxidasecoupled secondary antibodies. Protein signals were visualized using an enhanced chemiluminescence system (GE Healthcare, Pittsburgh, PA), and protein expression was calculated relative to that of GAPDH.
Statistical Analysis
Data were analyzed by Mann-Whitney U tests. Differences with P values <.05 were considered significant.
Results
NF-kB Decoy ODN Treatment Suppressed Periapical Lesion Development, NF-kB Activity, and CD31 Immunoreactivity
Radiographs from both the NF-kB decoy ODN-treated and the NF-kB decoy scramble-treated groups showed periapical radiolucency in the first molar (Fig. 1A and B) . In both groups, the pulp showed total necrosis and periapical lesions composed of a mass of granulation tissue with apical abscesses were developed (Fig. 1C and D) . The lesion size in the NF-kB decoy ODN-treated group was significantly smaller than that in the NF-kB decoy scramble-treated group (Fig. 1E) .
CD31+ endothelial cells were observed in all experimental groups ( Fig. 2A and B) . The CD31+ area in the NF-kB decoy ODN-treated group was significantly smaller than in the NF-kB decoy scramble-treated group (Fig. 2C) . NF-kB activity, assessed by measuring the levels of p65 in the nuclear fractions with ELISA, was significantly lower in the NF-kB decoy ODN-treated group than that in the NF-k B decoy scramble-treated group (Fig. 2D) .
NF-kB Decoy ODN Treatment Affected the Bax/Bcl-2 Ratio
Bax and Bcl-2 expression was observed in all experimental groups (Fig. 3A-D) . Bcl-2 and Bax were expressed in various types of cells, including endothelial cells (Fig. 3A-D) . The Bcl-2+ area in the NF-kB decoy ODN-treated group was significantly smaller than in the NF-kB decoy scramble-treated group (Fig. 3E) , whereas the Bax+ area was significantly larger in the NF-kB decoy ODN-treated group than in the NF-kB decoy scramble-treated group (Fig. 3F) . Thus, the Bax/Bcl-2 ratio in the NF-kB decoy ODN-treated group was significantly higher than that in the NF-kB decoy scramble-treated group (Fig. 3G) .
NF-kB Decoy ODN Treatment Decreased VEGF Expression, Down-regulated CXCL1, CXCR2, and VEGFR2 mRNA, and Up-regulated Bax mRNA
In Western blot analysis, VEGF expression in the NF-kB decoy ODN-treated group was down-regulated compared with that in the NF-kB decoy scramble-treated group (Fig. 4A) . Although there were no significant differences in the levels of Bcl-2 mRNA in CD31+ endothelial cells in both groups (Fig. 4B) , Bax mRNA levels in CD31+ endothelial cells in the NF-kB decoy ODN-treated group were up-regulated compared with those in the NF-kB decoy scramble-treated group (Fig. 4C) . The Bax/Bcl-2 mRNA ratio in the NF-kB decoy ODN-treated group was significantly increased compared with that in the NF-kB decoy scramble-treated group (Fig. 4D) . Notably CXCL1, CXCR2, and VEGFR2 mRNA in CD31+ endothelial cells in the NF-kB decoy ODN-treated group was significantly down-regulated compared with that in the NF-kB decoy scramble-treated group (Fig. 4E-G) .
Discussion
In this study, we found that NF-kB decoy ODN treatment reduced the activity of NF-kB and decreased the size of rat experimental periapical lesions 28 days after induction, when osteoclastic activity has decreased and the periapical lesion has stabilized (8) . The NF-kB p65 level in the nuclear fraction was significantly lower in the NF-kB decoy ODN-treated group than that in the control group, indicating that NF-kB decoy ODN reduced the nuclear translocation of NF-kB. Moreover, the density of CD31+ endothelial cells in NF-kB decoy ODN-treated animals was significantly decreased compared with that in NF-kB decoy scramble-treated animals. NF-kB inhibition increased Bax mRNA and decreased CXCL1, CXCR2, and VEGFR2 mRNA but did not affect the expression of Bcl2 mRNA in endothelial cells. Moreover, VEGF protein expression was down-regulated in NF-kB decoy ODN-treated animals. These results suggested that the reduction of periapical lesions by blocking NF-kB activity was associated with the inhibition of angiogenic pathways.
Bcl-2 and Bax are homologous proteins belonging to the Bcl-2 family but have opposite effects on cell survival and death; Bcl-2 prolongs cell survival, and Bax accelerates apoptosis (20) . The expression of Bcl-2 and Bax in the endothelial cells of periapical lesions was investigated to determine their roles in the regulation of angiogenesis in vivo through the inhibition of NF-kB. NF-kB has a crucial role in angiogenic and apoptotic responses (21) . Additionally, NF-kB activity is important in endothelial cell survival (22) , and NF-kB inhibition increases Bax expression (23) . Overexpression of Bax suppresses breast cancer growth in immunosuppressed mice (24) . Bax mRNA was up-regulated in CD31+ endothelial cells in NF-kB decoy ODN-treated animals. In contrast, there were no significant differences in Bcl-2 levels in both groups, and, thus, the Bax/Bcl-2 ratio increased in NF-kB decoy ODN-treated animals. These findings are consistent with the finding that NF-kB blockade up-regulates Bax and, subsequently, increases the Bax to Bcl-2 ratio and prevents the development of l-carrageenan-induced granulation tissue in rats (25) . The decrease of the Bcl-2-immunostained area in the NF-kB decoy ODN-treated group (Fig. 2E) could reflect the decrease of Bcl-2-expressing endothelial cells although the level of Bcl-2 mRNA in endothelial cells was similar in both groups (Fig. 3B) . Taken together, our findings suggest that an increase in the ratio of Bax/Bcl-2 in endothelial cells is associated with NF-kB decoy ODN-induced suppression of lesion development.
The present immunohistochemical analysis showed that the Bcl-2+ area in the NF-kB decoy ODN-treated animals was significantly smaller than that in the control animals, whereas there was no significant difference in the level of Bcl-2 mRNA in endothelial cells. Like a previous report regarding bcl-2 mRNA and protein expression in hepatocellular carcinomas (26) , it can be inferred that the difference between bcl-2 mRNA expression and the histologic pattern caused by a posttranslational mechanism of bcl-2 protein degradation indicates that bcl-2 does not play a substantial role in the progress of periapical lesions under NF-kB decoy ODN treatment.
In angiogenesis, VEGF regulates vascular permeability and promotes the proliferation and migration of endothelial cells (27) . VEGF specifically binds to and reacts with tyrosine kinase receptors, such as VEGFR1, -R2, and -R3. In particular, VEGFR2 is a major transducer of VEGF signals in endothelial cells (28) . VEGF mediates endothelial cell survival by inducing Bcl-2 expression in a pathway that requires VEGF binding to VEGFR2 and activation of phosphatidylinositol 3-kinase/Akt signaling (29) . VEGFR2 expression decreases in human umbilical vein endothelial cells after morusin treatment, which indicates that morusin promotes antiangiogenesis (30) . NF-kB is activated in endothelial cells exposed to VEGF, and if the activity of NF-kB is blocked, the expression of CXC chemokines, such as CXCL8 and CXCL1, is down-regulated (13). Thus, NF-kB regulates the expression of CXC chemokines that have critical roles in the regulation of angiogenesis during many pathological processes (13) . In this study, NF-kB decoy ODN treatment down-regulated CXCL1, CXCR2, and VEGFR2 mRNAs in endothelial cells and decreased VEGF protein expression in periapical lesions. In rats, CXCL1 and CXCR2 are related to growth-regulated oncogene/ cytokine-induced neutrophil chemoattractant 1, which is a rat homologue of human CXCL8 (also known as interleukin 8), a member of the CXC subfamily of chemokines (31, 32) . The density of CD31+ endothelial cells was decreased by decoy ODN treatment. These results suggested that inhibition of the VEGF/VEGFR2 system in endothelial cells, which subsequently down-regulates angiogenesis, is involved in the NF-kB decoy ODN-induced reduction of periapical lesion development.
In conclusion, we found that inhibition of NF-kB activity by decoy ODN treatment suppressed the development of experimentally induced periapical lesions with concomitant reduction of angiogenic responses in endothelial cells.
